An automated, highly sensitive LC-MS/MS assay for the quantification of the opiate antagonist naltrexone and its major metabolite 6β-naltrexol in dog and human plasma

被引:20
作者
Clavijo, Claudia [2 ]
Bendrick-Peart, Jamie [1 ,2 ]
Zhang, Yan Ling [2 ]
Johnson, Gillian [2 ]
Gasparic, Antje [3 ]
Christians, Uwe [1 ,2 ]
机构
[1] Eurofins Medinet, Aurora, CO 80045 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Anesthesiol, Aurora, CO USA
[3] Elbion AG, Radebeul, Germany
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2008年 / 874卷 / 1-2期
基金
美国国家卫生研究院;
关键词
Naltrexone; 6; beta-Naltrexol; LC-MS/MS; Column switching; Dog plasma; Human plasma;
D O I
10.1016/j.jchromb.2008.08.021
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To support animal studies and clinical pharmacokinetic trials, we developed and validated an automated, specific and highly sensitive LC-MS/MS method for the quantification of naltrexone and 6 beta-naltrexol in the same run. In human plasma, the assay had a lower limit of quantitation of only 5 pg/mL This was of critical importance to follow naltrexone pharmacokinetics during its terminal elimination phase. The assay had the following key performance characteristics for naltrexone in human plasma: range of reliable quantification: 0.005-100 ng/mL (r(2) > 0.99), inter-day accuracy (0.03 ng/mL): 103.7% and inter-day precision: 10.1%. There were no ion suppression, matrix interferences or carry-over. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 20 条
[1]  
Centre for Drug Evaluation and Research (CDER), 2001, GUID IND BIOAN METH
[2]   Quantification of naltrexone and 6,β-naltrexol in plasma and milk using gas chromatography-mass spectrometry -: Application to studies in the lactating sheep [J].
Chan, CF ;
Chiswell, GM ;
Bencini, R ;
Hackett, LP ;
Dusci, LJ ;
Ilett, KF .
JOURNAL OF CHROMATOGRAPHY B, 2001, 761 (01) :85-92
[3]   Determination of naltrexone and its major metabolite, 6-beta-naltrexol, in human plasma using liquid chromatography with electrochemical detection [J].
Davidson, AF ;
Emm, TA ;
Pieniaszek, HJ .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1996, 14 (12) :1717-1725
[4]   Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels [J].
Foster, J ;
Brewer, C ;
Steele, T .
ADDICTION BIOLOGY, 2003, 8 (02) :211-217
[5]   THE ROLE OF NALTREXONE IN THE MANAGEMENT OF DRUG-ABUSE [J].
GINZBURG, HM ;
MACDONALD, MG .
MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1987, 2 (02) :83-92
[6]   NALTREXONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF OPIOID DEPENDENCE [J].
GONZALEZ, JP ;
BROGDEN, RN .
DRUGS, 1988, 35 (03) :192-213
[7]  
GRANT JE, 2002, ANN CLIN PSYCHIAT, V3, P155
[8]   A LC-Electrospray tandem MS method for the analysis of naltrexone in canine plasma employing a molecular model to demonstrate the absence of internal standard deuterium isotope effects [J].
Iyer, Sunil S. ;
Kellogg, Glen E. ;
Karnes, H. Thomas .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2007, 45 (10) :694-700
[9]  
Kambia K, 2000, BIOMED CHROMATOGR, V14, P151, DOI 10.1002/1099-0801(200005)14:3<151::AID-BMC941>3.0.CO
[10]  
2-E